HOME › COMPANIES › DENALI THERAPEUTICS
EMERGING PUBLIC BIOTECH

DENALI THERAPEUTICS (DNLI)

California, USA · North America
NEUROSCIENCE
NEURODEGENERATION
EMERGING PUBLIC BIOTECH
HEADQUARTERS
California, USA
TICKER
DNLI
SEGMENT
Emerging Public Biotech
THERAPY AREAS
Neuroscience, neurodegeneration
KEY PRODUCTS
PRODUCTDETAILS
DNL343—
DNL788—
DNL126—
COMPANY OVERVIEW

Biotech focused on neurodegenerative diseases and CNS drug delivery technologies.

DENALI THERAPEUTICS — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →